日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study

乌帕替尼与阿达木单抗治疗类风湿性关节炎患者的长期安全性和有效性:来自 3 期随机 SELECT-COMPARE 研究的 5 年数据

Fleischmann, Roy; Swierkot, Jerzy; Penn, Sara K; Durez, Patrick; Bessette, Louis; Bu, Xianwei; Khan, Nasser; Li, Yihan; Peterfy, Charles G; Tanaka, Yoshiya; Mysler, Eduardo

Upadacitinib monotherapy versus methotrexate monotherapy in patients with rheumatoid arthritis: efficacy and safety through 5 years in the SELECT-EARLY randomized controlled trial

在类风湿性关节炎患者中,乌帕替尼单药治疗与甲氨蝶呤单药治疗的疗效和安全性比较:SELECT-EARLY随机对照试验5年随访结果

van Vollenhoven, Ronald; Strand, Vibeke; Takeuchi, Tsutomu; Chávez, Nilmo; Walter, Pablo Mannucci; Singhal, Atul; Swierkot, Jerzy; Khan, Nasser; Bu, Xianwei; Li, Yihan; Penn, Sara K; Camp, Heidi S; Aelion, Jacob

Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study

SELECT-COMPARE 研究中 upadacitinib 或 adalimumab 治疗类风湿性关节炎患者的长期安全性和有效性:3 年结果

Fleischmann, Roy; Mysler, Eduardo; Bessette, Louis; Peterfy, Charles G; Durez, Patrick; Tanaka, Yoshiya; Swierkot, Jerzy; Khan, Nasser; Bu, Xianwei; Li, Yihan; Song, In-Ho

Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts

GWAS 鉴定的类风湿关节炎抗 TNF 药物反应变异的验证:两大队列的荟萃分析

Jose Manuel Sánchez-Maldonado, Rafael Cáliz, Miguel Ángel López-Nevot, Antonio José Cabrera-Serrano, Ana Moñiz-Díez, Helena Canhão, Rob Ter Horst, Luca Quartuccio, Signe B Sorensen, Bente Glintborg, Merete L Hetland, Ileana Filipescu, Eva Pérez-Pampin, Pablo Conesa-Zamora, Jerzy Swierkot, Alfons A d

Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients

miRNA-5196表达变化作为类风湿性关节炎和强直性脊柱炎患者抗TNF-α治疗的潜在生物标志物

Ciechomska, Marzena; Bonek, Krzysztof; Merdas, Michal; Zarecki, Patryk; Swierkot, Jerzy; Gluszko, Piotr; Bogunia-Kubik, Katarzyna; Maslinski, Wlodzimierz

The role of microRNA-5196 in the pathogenesis of systemic sclerosis

microRNA-5196 在系统性硬化症发病机制中的作用

Marzena Ciechomska, Patryk Zarecki, Michal Merdas, Jerzy Swierkot, Ewa Morgiel, Piotr Wiland, Wlodzimierz Maslinski, Katarzyna Bogunia-Kubik

Family history and APOE4 risk for Alzheimer's disease impact the neural correlates of episodic memory by early midlife

家族史和APOE4基因携带者罹患阿尔茨海默病的风险会影响中年早期情景记忆的神经关联。

Rajah, M N; Wallace, L M K; Ankudowich, E; Yu, E H; Swierkot, A; Patel, R; Chakravarty, M M; Naumova, D; Pruessner, J; Joober, R; Gauthier, S; Pasvanis, S

Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement

最晚期类风湿关节炎患者在接受 TNF 抑制剂治疗后,尽管临床症状有所改善,但仍存在 Th1 系统性缺陷

Agata Kosmaczewska, Jerzy Swierkot, Lidia Ciszak, Aleksandra Szteblich, Agnieszka Chrobak, Lidia Karabon, Anna Partyka, Jacek Szechinski, Piotr Wiland, Irena Frydecka

Alterations in both the activatory and inhibitory potential of peripheral blood CD4+ T cells in rheumatoid arthritis patients correlate with disease progression

类风湿性关节炎患者外周血CD4+ T细胞的激活和抑制潜能的改变与疾病进展相关。

Kosmaczewska, Agata; Ciszak, Lidia; Swierkot, Jerzy; Szteblich, Aleksandra; Wiland, Piotr; Frydecka, Irena

Activation dependent apoptosis of peripheral blood mononuclear cells from patients with rheumatoid arthritis treated with methotrexate

甲氨蝶呤治疗类风湿性关节炎患者外周血单核细胞的激活依赖性凋亡

Swierkot, J; Miedzybrodzki, R; Szymaniec, S; Szechinski, J